Diabetes Update 2021

30/04/2021 01/05/2021

Learning Objectives

By the end of the congress, participants will be able to:

- Discuss the results and practical implications of the latest clinical trials for the management of patients with type 1 and type 2 diabetes
- Utilize lifestyle and pharmacological approaches to the prevention and treatment of diabetes complications
- Explain the latest guidelines and their implications on clinical practice
- Describe the role of evidence-based medicine and how it applies to health care decision making

Agenda

Symposia & Corridor Consults

Click the links below for more information about the symposia and Corridor Consults being presented at Diabetes Update 2021

Click here: Corridor Consults
Click here: Symposia (non-accredited)
Click here: Accredited Symposia

Accreditation

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Society of Endocrinology and Metabolism. You may claim a maximum of 13.0 hours (credits are automatically calculated). Participants should only claim credits commensurate with the extent of their participation in the activity.

Twitter

                                                                                                 


                                             
Follow @DUcongress and join the conversation at #DUcongress21

Registration Fees

Early Bird Registration Fees (until March 31): 
Specialists and Family Physicians $29
Scientists and Researchers $29
Registered Nurses, Diabetes Educators, Pharmacists, Other Allied Health Professionals $19
Residents, Students, and Fellows - Free

Regular Registration Fees (as of April 1):
Specialists and Family Physicians $49
Scientists and Researchers $49
Registered Nurses, Diabetes Educators, Pharmacists, Other Allied Health Professionals $29
Residents, Students, and Fellows – Free

Registration through this website is limited to health care professionals

Taxes not included

Contact Us

For more information, contact EOCI Pharmacomm (Organizing Committee)
contact@diabetesupdate.ca 

Planning Committee

Planning Committee Chair


  • Alice Y.Y. Cheng (She/Her)

    MD, FRCPC

    Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and is an Associate Professor at the University of Toronto.  She has been involved with the development of the Diabetes Canada clinical practice guidelines since 2003 served as Chair for the 2013 version.  Currently, she is the Chair of the Professional Section of Diabetes Canada and an Associate Editor for the Canadian Journal of Diabetes.

    In recognition of her contribution, she has received the national Charles H. Best Award and the Gerald S. Wong Service Award from Diabetes Canada.  She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education (www.theMedEdPledge.com) 

Planning Committee


  • Zaina Albalawi (She/Her)

    MD, MSc, FRCPC

    Zaina Albalawi is an Endocrinologist and Clinical Assistant Professor at Memorial University. She completed her Internal Medicine and Endocrinology training at the Univeristy of Alberta, along with a masters degree in Clinical Epidemiology.

    She co-authored the Foot Chapter for the 2018 Diabetes Canada Guidelines, and previously lead a multidisciplinary high-risk diabetic foot clinic at the Royal Alexandria Hospital in Edmonton. She’s currently a member of the Atlantic Collaborative Working group on diabetic foot prevention to develop policy and healthcare recommendations to reduce amputations in the region.
  • Jeffrey Habert

    MD, CCFP, FCFP

    Dr. Jeffrey Habert is a Family Physician in Thornhill for the last 28 years. He is an Assistant Professor in the Dept. of Family and Community Medicine at the University of Toronto. Dr. Habert is also a Peer Assessor for the College of Physicians and Surgeons of Ontario, Investigating Coroner for the City of Toronto and a Peer Leader at OntarioMD. He has an interest in the use of clinical practice guidelines, and has participated on committees to establish guidelines in the areas of Depression, Stroke and Thrombosis.

    He has recently served on the Scientific Committee for the 2016-2017 Canadian Stroke Prevention Guidelines and is the Co-Chair of Thrombosis Canada Guidelines Committee. He is also on the 2017 Canadian Stroke Congress planning committee. Dr. Habert is very involved in the continuing education of Family Physicians in the areas of Thrombosis/Stroke, Diabetes, Osteoporosis, and Depression.
  • Jacob A. Udell

    MD, MPH, FRCPC

    Dr. Udell is a Cardiologist and Clinician-Scientist at Women's College Hospital and the Peter Munk Cardiac Centre at the University Health Network and an Associate Professor of Medicine at the Univerisity of Toronto. He and his group's focus is in the conduct of large observational studies and clinical trials testing strategies and treatements for primary and secondary prevention of ischemic heart disease and heart failure.

    As a co-PI, national lead investigator, or steering committee member, he has recently published the INVESTED randomized controlled trial, which investigated the cardiovascular benefit of a high-dose versus usual-dose influenza vaccine; as well as the SCORED trial, studying sotagliflozin in patients with type 2 diabetes and chronic kidney disease. Currently he is the co-PI of a CIHR SPOR Innovative Clinical Trial Grant testing a provincial report card strategy on primary care performance measures for cholesterol management and also a co-lead of the international, multicentre EMPACT-MI trial, testing the early use of an SGLT2 inhibitor in high-risk heart attack patients to prevent the onset of heart failure. 

Faculty


  • Toniya Singh

    MD, FACC

  • George Thanassoulis

    MD, MSc, FRCP(C)

    Dr. Thanassoulis is the Director of Preventive and Genomic Cardiology at the MUHC and an Associate Professor of Medicine at McGill University.  His clinical interests are in cardiovascular prevention, dyslipidemia (specifically lipoprotein[a]) and premature coronary artery disease.  He currently runs the MUHC Family Heart Clinic for patients with premature CAD and their families with the goal of optimizing their preventive care.   His research interests are in the genetics of aortic valve stenosis where he leads an international consortium investigating the role of genomic variation in this disease.  He is also working on developing new approaches to optimize cardiovascular prevention in young individuals.   He is the co-Chair of the 2021 CCS Dyslipidemia Guideline Committee. 

  • Gillian Booth

    MD, MSc

    Dr. Gillian Booth is a Scientist at MAP Centre for Urban Health Solutions within the Li Ka Shing Knowledge Institute of St. Michael’s Hospital in Toronto. Dr. Booth is also an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES), a Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto, and a practicing endocrinologist. Dr. Booth’s research focuses on health outcomes related to diabetes; specifically how socioeconomic, environmental and health care factors influence the risk of diabetes and its complications.

    She has extensive experience in using large provincial health care and survey databases, and in using geographic information systems (GIS) methodology to study contextual factors influencing the development of diabetes. One of her major research interests is on the built environment and its role in the obesity and diabetes epidemics. Dr. Booth has made major contributions to diabetes policy and practice at both the national and provincial levels. She has served on several advisory committees for the Public Health Agency of Canada’s Canadian Chronic Disease Surveillance System and she was the Methodology Chair for the 2013 Canadian Diabetes Association Clinical Practice Guidelines.
  • Jennifer Yamamoto

    MD, MSc, FRCPC

    Dr. Yamamoto is an endocrinologist and clinician researcher at the University of Manitoba and an adjunct assistant professor at the University of Calgary. She completed her medical school and internal medicine residency at the University of Manitoba. She subsequently completed her Endocrinology training and MSc in Clinical Epidemiology at the University of Calgary and furthered a one-year research fellowship in diabetes in pregnancy at the University of East Anglia in the United Kingdom. Dr. Yamamoto’s main research and clinical interests include diabetes in pregnancy and thyroid disease preconception, during pregnancy, and postpartum.
  • Julie A. Lovshin

    MD, PhD, FRCPC

    Dr. Julie Lovshin is a Clinician Scientist and Assistant Professor of Medicine in the Division of Endocrinology and Metabolism, Department of Medicine, at the University of Toronto.  Dr. Lovshin is an Endocrinologist who specializes in diabetes clinical care, with an emphasis on renal and cardiovascular complications. Dr. Lovshin directs the Diabetes Complications Clinical Research Laboratory at Sunnybrook Health Sciences Research Centre, Toronto, Canada, where her research is focused on mechanistic human investigation in renal, retinal and cardiovascular disease.

    Dr. Lovshin’s research training includes a PhD at the University of Toronto, supervised by Dr. Daniel Drucker on incretin hormones, including GLP-1 and GLP-2. After her medical training and residency at the University of Toronto, she completed a post-doctoral research fellowship as an Eliot Phillipson Scholar with Dr. David Cherney and Dr. Daniel Drucker, in clinical investigation focused on renal and hemodynamic function in Type 2 diabetes. She also trained with Dr. Bruce Perkins co-leading the Canadian Study for Longevity in Type 1 Diabetes. Dr. Lovshin has also completed research methodology and epidemiology training at the Harvard School of Public Health, Boston, MA.
  • Lawrence A. Leiter

    MD, FRCPC, FACP, FACE, FAHA, FACC, FCAHS

    Dr. Lawrence A. Leiter is Director of the Lipid Clinic; Associate Director of the Clinical Nutrition and Risk Factor Modification Centre; and Associate Scientist, Li Ka Shing Knowledge Institute at St. Michael’s Hospital in Toronto where he was also the Head of the Division of Endocrinology and Metabolism from 2000-2010. He is a Professor in the Departments of Medicine and Nutritional Sciences at the University of Toronto.

    Dr. Leiter has several research interests including clinical trials on the prevention of atherosclerosis, especially in diabetes, and the dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity. He has over 750 publications in peer-reviewed journals. He was an investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and is on the Executive/Steering Committees of many ongoing outcome trials in both the diabetes and lipid areas. In 2018, 2019, and 2020 he was a Clarivate Analytics Top 1% Highly Cited Researcher.

    Dr. Leiter is a Past-President of the Canadian Society of Endocrinology & Metabolism (CSEM) and a past Chair of the Clinical and Scientific Section of the Canadian Diabetes Association (CDA). He has been involved in many national and international committees and consensus conferences including those of the International Diabetes Federation, CDA, Canadian Hypertension Education Program (CHEP), Canadian Cardiovascular Society (Dyslipidemia), and Obesity Canada. He is an Associate Editor of the journal Diabetes Care.

    For his work, he has received a number of awards including the CDA Frederick G. Banting Award and the American Diabetes Association Charles H Best Award (awarded to DCCT investigators), both for Distinguished Service, the 2005 CSEM Educator of the Year Award, and the 2006 CDA Gerald S. Wong Award in recognition of significant contributions to the diabetes community. He was the inaugural winner of the St. Michael’s Hospital Complete Physician Award in 2009. He is also the 2016 recipient of both the CDA Lifetime Achievement Award for Research Excellence and the CSEM Robert Volpe Distinguished Service Award. In 2019 was elected as a Fellow of the Canadian Academy of Health Sciences.
  • Louise Moist

    MD, MSc, CCPE

    Dr. Moist is a Clinician Researcher and Professor of Medicine, Epidemiology and Biostatistics at the University of Western Ontario, Associate Chair, Division of Nephrology, Associate Director of the Center for Quality Improvement and Patient Safety at Schulich School of Medicine and Dentistry and the Clinical Lead for the South West.

    Dr Moist is a Certified Canadian Physician Executive, credentialing her significant role in healthcare leadership. Dr Moist is an active clinician, teacher and researcher.  Dr Moist’s publications include over 200 peer reviewed papers and her recent research is in Implementation Science, integrating best evidence to best practice.
  • Peter Lin

    MD, CCFP

    Dr. Peter Lin began his studies in the Faculty of Science and Engineering at the University of Toronto in Toronto, Ontario. Midway through, he moved to the Faculty of Medicine, where he completed his studies and became involved in research. Over the years, it became apparent to him that there was a wide chasm between research and clinical practice, and he moved into clinical practice in primary care and eventually into teaching in order to help bridge this gap. He served as the medical director at the Health & Wellness Centre, University of Toronto Scarborough, for 7 years. Currently, he is the Director of Primary Care Initiatives at the Canadian Heart Research Centre. He lectures and speaks throughout the world and maintains two busy family practices in Toronto.

    Dr. Lin is a consultant for Perspectives in Cardiology, and is on the editorial board of The Canadian Review of Alzheimer's Disease and Other Dementias (formerly, The Canadian Alzheimer Disease Review). He has been the chairman of the Dementia Congress in the US for the last 4 years. He has also served on the editorial board of Pri-Med, a US company that provides education for physicians. Dr. Lin received a teaching award from the College of Family Physicians in 2011.
  • Peter Senior

    BMedSci (Hons), MBBS(Hons), PhD, FRCP(E), FRCP

    Dr. Peter Senior is Professor in the Division of Endocrinology and Metabolism, and Medical Director of the Clinical Islet Transplant Program at the University of Alberta, in Edmonton, Canada.

    He is originally from the UK where he completed his specialist training in Diabetes and Endocrinology and received his PhD in 2002.

    His clinical and research interests focus on type 1 diabetes, islet transplantation and diabetic nephropathy.

    Currently he is Past-Chair of the Professional Section of Diabetes Canada, Chair of the Diabetes Canada Clinical Practice Guidelines and a member of the Diabetes Canada Board of Directors.
  • Rémi Rabasa-Lhoret

    MD, PhD

    Rémi Rabasa-Lhoret (MD;PhD) is Vice President (clinic & clinical research) at IRCM, professor of 
    medicine and nutrition at Université de Montréal and endocrinologist of CHUM. He holds two diabetes research chairs, funding from multiple agencies, has published over 300 manuscripts, contributed to national and international treatment recommendations and received multiple prizes and awards.

    His main goal is to reduce the frequency and consequences of hypoglycemia (low blood sugar induced by insulin) for patients living with type 1 diabetes and has been a leader for the development of artificial pancreas. He also investigates causes and consequences of diabetes in patients living with cystic fibrosis.
  • Sean Wharton

    MD, FRCPC, PharmD

    Dr. Wharton has his doctorate in Pharmacy and Medicine at the University of Toronto.  He is the medical director of the Wharton Medical Clinic, a community based internal medicine weight management and diabetes clinic.  He is an adjunct professor at McMaster University in Hamilton and York University in Toronto.  He also academic staff at Women’s College Hospital, and clinical staff the Hamilton Health Sciences.  Dr. Wharton’s research focuses on bariatric medicine and type 2 diabetes.  He is the co-lead authour of the Canadian Obesity Guidelines.

    Dr. Wharton is involved activism to achieve health equity in Canada.  He founded the BMSA (Black Medical Students Association) at the University of Toronto in 2000. The BMSA is now a recognized mentorship organization across Canada.
  • Tarry Ahuja

    PhD

    Dr. Tarry Ahuja is currently the Manager of Program Development in Pharmaceutical Reviews and Sr. RWE Advisor lead at the Canadian Agency for Drugs and Technology in Health, the leading HTA agency for Canada. Prior to this he was a senior medical real-world evidence scientist for Eli Lilly for Europe and Canada. He is also currently a lecturer at Carleton University teaching “Biological Foundations of Addictions” and “Health Psychology”.  He holds a PhD in Neuroscience with a specialty in electrophysiology and pharmacology from Carleton University, Ottawa, Canada.

    He has worked for over 10 years in the hospital setting in the area of sleep disorders and has over 10 years of clinical research in the areas of otolaryngology, Alzheimer’s, stroke and ischemia with the National Research Council of Canada.
  • Theodore Wein

    MD, FRCPC

    Dr. Theodore Wein MD, FRCPC, FAHA is an Assistant Professor of Neurology and Neurosurgery at McGill University where he works at the Stroke Prevention Clinic and is a William Osler Fellow. He completed his Neurology training at the Montreal Neurological Institute and went on to do his fellowship in Cerebrovascular Disease at the University of Texas – Houston.

    Dr. Wein is currently the co chair of the Canadian Stroke Prevention Guidelines and also sits on the Board of the Canadian Stroke Consortium where he heads the Policy and Advocacy committee focused on improving stroke care across Canada. Devoted to education Dr. Wein has chaired the annual American Heart Association International Stroke Conference pre-conference “stroke in the real world” and also sits on the steering Committee of the Canadian Stroke Congress.

    Dr. Wein is actively involved in stroke clinical trials and has a particular interest in stroke recovery and rehabilitation. He is lead author in the recently completed REFLEX trial looking at efficacy of botulinum toxin in treating post stroke spasticity.

Faculty - Symposia & Corridor Consults


  • Akshay Jain

    MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM

    Dr. Akshay Jain is the first Canadian physician to be triple board-certified by the American Boards in Endocrinology, Internal Medicine and Obesity Medicine.

    He trained in Internal Medicine at Rochester, New York, where he became the only 4-time winner of the prestigious Rochester Academy of Medicine Award. He completed his Fellowship in Endocrinology at Harbor UCLA in Los Angeles, California. He holds the distinction of being the youngest physician to sit on the Board of Directors of the American Association of Clinical Endocrinologists. He is the Past President of the Canadian Chapter of the American Association of Clinical Endocrinologists.

    He is the first North American physician to win the prestigious Etzwiler Diabetes Scholarship at the International Diabetes Center and Mayo Clinic in MN, USA. In 2017, he was awarded the Rising Star of Diabetes Award at the International Symposium on Diabetes.

    In 2020, he became the only non-American physician to feature on Medscape’s list of 25 Top Rising Stars of Medicine.

    He is fluent in 6 languages including English, Hindi, Gujarati, Marathi, Marwari and Urdu. He is a renowned educator and has spoken at over 700 medical conferences/events across the world till date. His clinical interests include diabetes, obesity, thyroid disorders and osteoporosis.
  • Alescia Azzola

    MD, FRCPC

    Dr Azzola is an Endocrinologist in the community of Sudbury since 2018. She is a proud graduate of the Northern Ontario School of Medicine. She completed her Internal Medicine Residency as well as Endocrinology and metabolism fellowship at the University of Western Ontario. She has a special interest and research focus in pituitary, adrenal and genetic disorders. She is currently involved in trials regarding hypogonadism, congenital adrenal hyperplasia, and screen time neuropeptide variations.

  • Alexander Abitbol

    MDCM, FRCPC

    Dr. Alex Abitbol is an endocrinologist and assistant medical director at LMC Healthcare. He joined LMC in 2015 after relocating to Toronto. He completed medical school, residency and subspecialty training in endocrinology at McGill University. He received certifications in Internal Medicine and Endocrinology & Metabolism by the Royal College of Physicians and Surgeons of Canada and the American Board of Internal Medicine.

    Dr. Abitbol is committed to treating patients in all areas of endocrinology. He strives to support the relevance of primary care education and remains an avid speaker locally and abroad. He also has a particular interest in applying technology towards improving diabetes care and management, and some of his early research focused on developing automated insulin therapy. 
     
  • Amel Arnaout

    MD, FRCPC

    Dr. Amel Arnaout is an Assistant Professor in the Faculty of Medicine at the University of Ottawa and the Director of Postgraduate Medical Education and Fellowship Program for the Department of Medicine at The Ottawa Hospital. She is the Clinical Director of the University of Ottawa Heart Institute Diabetes Program where her team has developed nationally recognized protocols for the care of high-risk patients with diabetes and heart disease.
  • Arthur Vasquez

    MD, CCFP

    Dr. Vasquez is a family physician and Medical Director of Marine Gateway Medical Clinic in Vancouver, with a special practice interest in chronic disease management. 
    He is a clinical faculty member at the University of British Columbia, mentoring medical students and family practice residents. He has also been involved in clinical research both as a principal investigator and Associate Medical Director for the pharmaceutical industry for multiple therapeutic areas including diabetes. 
  • Basel Bari

    MD, MCFP

    Dr. Bari works as a Family Physician in Markham, Ontario. Since 1995, he has invested time in his In/Out-patient practice with an area of focus in Diabetes, Cardiology, Chronic Disease Management.
  • Daniel Ngui

    BScPT, MD, FCFP

    Dr. Daniel Ngui is a family physician and clinical lead for a group practice of 7 family physicians and one NP at Fraser Street Medical in South Vancouver.  He is a clinical professor with the UBC Dept of Family Medicine involved in teaching medical trainees and is involved with the BC guidelines and the Canadian Cardiovascular Society. He is interested in knowledge translation of guidelines and is involved in developing primary care educational programs at the local, regional and national level.  
  • Harpreet S. Bajaj

    MD, MPH, FACE

    Harpreet Singh Bajaj is an Endocrinologist and Director of Late-phase research at LMC Healthcare. Dr Bajaj completed his clinical fellowship at the Cleveland Clinic (Ohio, USA). Dr Bajaj’s medical education was at University of Delhi, India, following which he attained a Masters of Public Health (Epidemiology) at State University of New York in Albany (New York, USA).

    Dr. Bajaj is a Research Associate at Mount Sinai Hospital, Toronto and an adjunct lecturer at McMaster University. He has co-authored publications in key medical journals in the fields of diabetes prevention and management, obesity and cardiovascular risk assessment.

    He is the Principal Investigator of the Canadian Diabetes Prevention Program, a nationwide collaborative effort between LMC, Diabetes Canada and the Public health agency of Canada.

    Dr. Bajaj currently serves Diabetes Canada on the professional section national executive and as the Vice-Chair of the Clinical Practice Guidelines (CPG). 
  • James Kim

    MBBCh, PgDip(Diabetes)

    Dr Kim is a general practitioner in Calgary with special interest in chronic disease, especially in diabetes and chronic migraine. He is a clinical assistant professor in the Department of Family Medicine at University of Calgary.

    After graduating from his medical school in South Africa, he has completed post-graduate diploma in Diabetes in 2012 and works as a peer reviewer and editorial board member for numerous medical journals including Canadian Journal of Diabetes. He has also given numerous presentations locally and nationally on the topics of diabetes, chronic migraine, binge eating disorder, ADHD, and respiratory medicine. He has also been involved in numerous CME slide deck development.

    Within Diabetes Canada, his role includes steering committee member for the Clinical Practice Guideline, current co-chair of Primary Care Special Interest Group, Dissemination and Implementation member and has been a scientific planning committee member for the Annual Diabetes Canada Conference.

    He is currently involved with PIONEER REAL research as the site lead investigator.

  • Jill Trinacty

    MD, FRCPC

    Dr. Trinacty is originally from Nova Scotia, where she obtained her Bachelor of Science (Honours) degree at Saint Francis Xavier University in Antigonish.  She completed her medical degree at Dalhousie University in 2013.  Dr. Trinacty moved to Ottawa, Ontario for residency in Internal Medicine and specialization in Endocrinology and Metabolism at The Ottawa Hospital.

    Dr. Trinacty was Chief Resident for the University of Ottawa Endocrinology and Metabolism program during her final year of training.   She was recognized for her patient advocacy as the recipient of the Diabetes Canada Resident Award for Advocacy & Leadership, as well as the CANMEDs Health Advocate Award.

    She practices at LMC Ottawa, Bariatric Medical Institute and Wharton Medical Clinic. She is a consultant and affiliate researcher with Bruyere Continuing Care. She is presently a lecturer at the University of Ottawa and provides ongoing medical education through speaking engagements for other health care professionals including family physicians, diabetes educators and pharmacists.  She also serves as Vice Chair of the Endocrinology Section for the OMA.
  • Kimberley Hanson

    Diabetes Canada

    Kimberley Hanson is Executive Director of Federal Affairs at Diabetes Canada, responsible for advocacy with the federal government and on national issues. She also leads the Diabetes 360˚ initiative to implement a nation-wide strategy to address the diabetes epidemic.

    Having lived with diabetes for nearly 25 years, Kim is passionate about helping others live well with the disease while also working towards a cure. Over the past 15 years, Kim and her family have raised more than $1 million for research into a cure for diabetes and for supports for adults living with type 1 diabetes. Prior to joining Diabetes Canada, Kim held various senior management positions in Communications, Business Development and Human Resources at Payments Canada and Export Development Canada.
  • Lara Katz

    Lara Katz is a registered dietitian who has been working in the field of diabetes for the past 5 years. During that time Lara has found working with adults diagnosed with LADA of particular interest, and enjoys trying to make life with diabetes easier for them. One of those ways has been starting patients with Lada on the Omnipod pump!

    During her spare time Lara spends time with her family, including her husband, 3 young boys and new puppy. Lara also loves to cook & bake.
  • Lori Berard

    Lori Berard has over 30 years of experience in diabetes education, management and clinical research working as the Nurse Manager for the Health Sciences Centre Diabetes Research Program and a Faculty Member at the University of Manitoba Department of Medicine Section of Endocrinology. 

    Currently she is working as a consultant in diabetes management and clinical research operations. Lori has dedicated many years  volunteering with Diabetes Canada and has extensive experience with the Clinical Practice Guidelines.  She has received many honors and awards related to her work in diabetes.

     

  • Marie-Andrée Corbeil

    MD, BPharm, FRCP

    Dr. Marie-Andrée Corbeil works as a general endocrinologist in a community area south of Montreal. She is the responsible physician of the chronic disease centre at CISSS Montérégie Centre site Haut-Richelieu. Since her brief career as a pharmacist, she dedicates most of her time treating patients with diabetes.
  • Naveed Sattar

    Naveed Sattar graduated from the University of Glasgow in 1990. In early 1992 he took up a post as a senior house officer (SHO) at Edinburgh Royal Infirmary; returning to Glasgow later that year as an SHO at the Victoria Infirmary. In 1993 he moved to Glasgow Royal Infirmary, first as a Specialist Registrar then as Senior Lecturer and Reader. He was awarded a PhD from the University of Glasgow in 1998.

    He joined the staff of the University of Glasgow in 1999 and in early 2005 was appointed as Professor of Metabolic Medicine at the Institute of Cardiovascular & Medical Sciences. He continues as an Honorary Consultant in Metabolic Medicine at the Glasgow Royal Infirmary, where he co-leads a CVD prevention clinic. He is a Fellow of the Royal College of Pathologists, the Royal College of Physicians and Surgeons, Glasgow, the Royal Society of Edinburgh, and the UK Academy of Medical Sciences.

    He is regularly asked to speak at international conferences and has sat on several national and international guideline committees, including: European Society of Cardiology (ESC) Task Force to develop 2019 Guidelines on diabetes, prediabetes, and cardiovascular diseases; Joint British Societies 3 CVD prevention recommendations; SIGN obesity and CVD prevention guidelines (latter as Chair); and European CVD prevention guidelines.

    Naveed is currently involved in several lifestyle and drug trials in diabetes and CVD and leads on biomarker initiatives in other trials. He is on the editorial board for BMC Medicine and is an Associate Editor for Circulation. He has previously been on committees for Diabetologia, Diabetes Digest, Diabetes UK, European Association for Study of Diabetes (EASD), Lancet Diabetes and Endocrinology, American Diabetes Association, Scotland’s Chief Scientist Office, and British Heart Foundation. He is on the UK Biobank Enhancements committee.

    He has authored / co-authored over 1000 published papers and received several national and international prizes for his research, including the Rank Nutrition Lecture, Minkowski and Camillo Golgi Award Lectures, Dorothy Hodgkin Lecture, the John French Lecture and the RD Lawrence Lecture. Naveed has been in the top 1% of cited clinical academics in the world since 2014, according to the annual Clarivate Analytics Highly Cited Researcher list.  However, above all, he is a Glaswegian (or Weegie) at heart, enjoying walks with his wife and dog as well as weekly soccer and cycling in the ‘lovely’ West of Scotland weather.
  • Ron White

  • Ronald Goldenberg

    MD, FRCPC, FACE

    Dr. Ronald Goldenberg is a consultant endocrinologist affiliated with LMC Diabetes & Endocrinology in Vaughan, Ontario. He completed his residency in Internal Medicine in 1987 at the University of Toronto, and his fellowship in Endocrinology & Metabolism in 1989 at the University of Toronto.  His major areas of interest include clinical care of diabetes, obesity, dyslipidemia, and thyroid disorders.

    Dr. Goldenberg has been an investigator in a wide array of clinical trials in the areas of diabetes, hypertension, obesity, and dyslipidemia. He has been actively involved in Continuing Medical Education for the last 3 decades, with a strong focus on translating evidence-based medicine into practical patient care. Dr. Goldenberg was a councillor on the Diabetes Canada Clinical & Scientific Section Executive Committee from 2010 to 2016. He was a member of the Steering Committee and an author for the 2013 CDA Clinical Practice Guidelines, lead author of the CDA March 2016 Interim Update and co-author of the November 2016 Interim Update on the Pharmacologic Management of Type 2 Diabetes. He was on the Executive Committee and an author for the 2018 Diabetes Canada CPGs. Dr. Goldenberg was affiliated with North York Branson/North York General Hospital from 1989-2020 where he served as Medical Director of the Diabetes Education Centre. He is a past chair of the Ontario Medical Association Section on Endocrinology & Metabolism and a previous President of the Toronto Diabetes Association.
  • Sue Pedersen

    MD, FRCPC

    Dr. Sue Pedersen is a Specialist in Endocrinology & Metabolism and a Diplomate of the American Board of Obesity Medicine. She has a busy practice at the C-ENDO Diabetes and Endocrinology Clinic in Calgary. Dr. Pedersen is involved extensively in clinical research for obesity and diabetes. Furthermore, she is the lead author of the pharmacotherapy chapter on the 2020 Canadian Obesity Guidelines, and a member of the Expert Committee for the 2018 Diabetes Canada Guidelines.

    Dr. Pedersen has become a leading voice on how to treat diabetes and obesity and educates health care professionals globally.   She has a public information website about weight management and diabetes: www.drsue.ca
  • Susie Jin

    RPh, CDE CRE

    Susie is a community pharmacist, Certified Diabetes Educator, Certified Fitter of Compression Therapy and Certified Respiratory Educator. In addition to working in a busy community pharmacy, Susie has co-authored and supported dissemination and implementation of Diabetes Canada Guidelines and Wounds Canada Best Practice Recommendations.

    Susie has practiced diabetes education in a variety of settings and enjoys collaborating and working together remotely with the person’s diabetes team. In 2020, Susie was the honored with the Diabetes Canada Charles H. Best award, a national award that recognizes a healthcare professional who has made a significant difference across Canada towards improving the quality of life of individuals living with diabetes. Post COVID-19, Susie is very much looking forward to getting back to travelling with friends and family to run marathons slowly all over the world.
  • Conrad Pow

    Diabetes Action Canada

    Senior Project Manager at Diabetes Action Canada, managing the National Diabetes Repository, a virtual platform that enables secure analytics of primary care data.  His focus is on data governance and privacy-preserving record linkage.  His research work is currently focused on the marginalized and vulnerable populations and those with complex chronic conditions. Conrad studied Business Management at Sheridan College with a focus on Human Resources Management and served as the College’s Senator for Community and Liberal Studies. He further went on to receive a certificate in Project Management from the Schulich School of Business at York University.

    His youngest daughter, Chloe, was diagnosed with Type 1 Diabetes shortly after he joined Diabetes Action Canada. Together, they have become fierce advocates for Type 1 Diabetes. 

Sponsors


  • Boehringer Ingelheim-Lilly Alliance


  • Novo Nordisk


  • Becton Dickinson


  • Insulet Corporation


  • Sanofi


  • HLS Therapeutics


  • Abbott


  • AstraZeneca


  • Bayer


  • Janssen